Name: 글로벌 시장 동향
SKU: BT4084
Availability: InStock

보고서 요약(국문)

개요
글로벌 세포 신호 전달 시장은 2023년 YY백만 달러에 도달했으며, 2024년부터 2031년까지 연평균 성장률(CAGR) YY%로 성장하여 2031년에는 YY백만 달러에 이를 것으로 예상됩니다.
세포 신호 전달은 세포 표면과 내부의 신호 분자를 통해 외부 물질에 반응하는 과정입니다. 호르몬, 신경전달물질, 성장인자와 같은 화학 물질은 특정 단백질 수용체에 결합하여 세포 분열이나 사멸과 같은 세포 반응을 유도합니다. 세포 신호 전달은 정상적인 세포 성장과 기능에 필수적이며, 신호 분자의 이상은 암(신호 전달 장애)으로 이어질 수 있습니다.
시장 동향: 동인 및 제약 요인
만성 질환 유병률 증가
만성 질환 유병률의 증가는 세포 신호 전달 시장의 중요한 동인입니다. 암, 심혈관 질환, 당뇨병, 신경퇴행성 질환과 같은 만성 질환의 효과적인 치료법 개발을 위해서는 세포 메커니즘과 신호 전달 경로에 대한 심층적인 이해가 필요합니다.

예를 들어, 미국 질병통제예방센터(CDC)의 2024년 자료에 따르면, 미국에는 심장병, 암, 당뇨병, 비만, 고혈압 등을 포함한 주요 만성 질환을 하나 이상 앓고 있는 사람이 1억 2,900만 명에 달합니다. 미국에서 사망 원인 상위 10가지 중 5가지는 예방 및 치료가 가능한 만성 질환과 관련이 있습니다.
지난 20년간 만성 질환 유병률은 꾸준히 증가해 왔으며, 이러한 추세는 계속될 것으로 예상됩니다. 점점 더 많은 미국인들이 여러 만성 질환을 앓고 있는데, 42%는 두 가지 이상의 질환을, 12%는 다섯 가지 이상의 질환을 가지고 있습니다. 만성 질환은 미국 의료 시스템에도 상당한 영향을 미치며, 연간 4조 1천억 달러의 지출 중 90%가 이러한 질환의 관리 및 치료에 사용됩니다.

배아줄기세포 신호전달 연구와 관련된 윤리적 문제

줄기세포 연구는 인간 발달 및 분화를 이해하고 당뇨병, 척수 손상, 파킨슨병, 심근경색과 같은 질병에 대한 새로운 치료법을 개발하는 데 큰 가능성을 제시합니다. 그러나 난자와 배아로부터 만능 줄기세포주를 유도하는 과정에서 물질 기증 동의, 치료법의 초기 임상 시험, 연구 감독 등 윤리적, 정치적 논란이 발생합니다. 이러한 문제들은 배아 줄기세포 신호 전달 연구 시장의 성장을 저해하고 있습니다.

본 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
글로벌 세포 신호 전달 시장은 제품 유형, 신호 전달 유형, 경로, 기술, 최종 사용자 및 지역별로 세분화됩니다.

제품 유형 세그먼트 중 소모품은 세포 신호 전달 시장 점유율의 약 42.3%를 차지했습니다.
소모품 세그먼트는 유전체학 및 단백체학 분야의 발전과 맞춤형 의학 및 표적 치료에 대한 관심 증가 등의 요인으로 인해 성장이 예상됩니다.

정부와 민간 부문의 세포 기반 연구 자금 지원 증가는 전 세계 세포 신호 전달 산업의 성장을 견인할 것으로 예상됩니다. 예를 들어, 미국 국립보건원(NIH) 포털 데이터에 따르면 2021 회계연도에 줄기세포 연구에 약 450억 달러가 지원되었습니다. 배아줄기세포 및 유도만능줄기세포 연구에 대한 자금 지원 또한 2020년 3월에 유사하게 증가했습니다.
지역 분석
북미는 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
북미는 Thermo Fisher Scientific, Merck KGaA, Cell Signaling Technology Inc. 등 주요 기업들이 현지에 많이 위치하고 있으며, 주요 기업들의 혁신적이고 첨단적인 제품 개발을 위한 연구 개발 투자 증가가 지역 세포 신호 전달 산업 성장을 견인하는 요인으로 작용할 것으로 전망됩니다.

예를 들어, 생명과학 발견 기술 기업이자 항체, 키트 및 서비스 분야의 선도적인 공급업체인 셀 시그널링 테크놀로지(CST)는 2023년 9월에 중간 수준의 고처리량 면역조직화학(IHC) 분석법을 사용하는 공간 생물학 연구를 위한 혁신적인 새로운 도구인 시그널스타 멀티플렉스 IHC 기술을 출시했다고 발표했습니다.
시장 세분화
제품 유형별
• 소모품
• 기기
• 시약 및 키트
신호 유형별
• 내분비 신호 전달
• 주변분비 신호 전달
• 자가분비 신호 전달
• 시냅스 신호 전달
• 기타
경로별
• AKT 신호 전달 경로
• AMPK 신호 전달 경로
• ErbB/HER 신호 전달 경로
• 기타
기술별
• 유세포 분석
• 질량 분석
• 웨스턴 블롯팅
• ELISA
• 기타
최종 사용자별
• 병원
• 제약 및 생명공학 회사
• 학술 및 연구 기관
• 임상 연구 위탁 기관(CRO)
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 기타 아시아 태평양 지역
• 중동 및 아프리카
경쟁 환경
주요 글로벌 시장 참여 기업으로는 Thermo Fischer Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Merck KGaA, PerkinElmer Inc., Promega Corporation, Qiagen NV, Beijing Boshumei Biotechnology Co., Ltd 등이 있습니다.
주요 개발 사항
 2023년 2월, Bio-Techne Corporation과 Cell Signaling Technology(CST)는 CST 항체에 Simple Western 검증 기능을 추가했다고 발표했습니다. 이를 통해 다양한 분야의 연구자들은 신뢰할 수 있고 검증된 플랫폼에서 중요한 분자 신호 전달 경로를 더욱 쉽게 연구할 수 있게 되었습니다.

 2023년 5월, 화이자와 써모피셔 사이언티픽(Thermo Fisher Scientific Inc.)은 라틴 아메리카, 중동, 아프리카, 아시아 등 30개국 이상에서 차세대 염기서열 분석(NGS) 기반 폐암 및 유방암 환자 선별 검사의 접근성을 높이기 위한 파트너십을 발표했습니다. 이 지역들은 기존에 첨단 유전체 검사가 제한적이거나 이용할 수 없었던 곳입니다.

보고서 구매 이유:

• 제품 유형, 신호 전달 유형, 경로, 기술, 최종 사용자 및 지역별 글로벌 세포 신호 전달 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 세포 신호 전달 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 세포 신호 전달 시장 보고서는 약 64개의 표, 61개의 그림, 186페이지 분량입니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Cell Signaling Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031
Cell signaling is the process of responding to external substances through signaling molecules on its surface and inside. Chemical substances like hormones, neurotransmitters, and growth factors bind to specific protein receptors, producing cell responses like division or death. Cell signaling is crucial for normal cell growth and function, and abnormal signaling molecules may lead to cancer also known as signal transduction.
Market Dynamics: Drivers & Restraints
Rise in the prevalence of chronic diseases
The rise in the prevalence of chronic diseases is a significant driver of the cell signaling market. Chronic diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders require an in-depth understanding of cellular mechanisms and signaling pathways for the development of effective treatments.
For instance, according to CDC 2024, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases.
Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, with 90% of annual $4.1 trillion expenditure attributed to managing and treating these conditions.

Ethical issues related to embryonic stem cell signaling research

Stem cell research holds great promise for understanding human development and differentiation, and for developing new treatments for diseases like diabetes, spinal cord injury, Parkinson's disease, and myocardial infarction. However, ethical and political controversies arise during the derivation of pluripotent stem cell lines from oocytes and embryos, including consent to donate materials, early clinical trials of therapies, and oversight of research. These issues are hindering market growth in embryonic stem cell signaling research.

For more details on this report – Request for Sample
Segment Analysis
The global cell signaling market is segmented based on product type, signaling type, pathway, technology, end-user and region.
The consumables from the product type segment accounted for approximately 42.3% of the cell signaling market share
The consumables from the product type segment accounted for approximately 42.3%. The consumables segment is expected to grow due to factors like, the expanding number of advances in genomes and proteomics, as well as the growing emphasis on customized medicine and targeted therapies, are accelerating this segment's growth rate.
Growing government and private sector funding of cell-based research is predicted to propel the global cell signaling industry forward. For instance according to data from the National Institutes of Health (NIH) portal, an estimated USD 45 billion was provided for stem cell research in fiscal year 2021. Similar increases in funding grants for research on embryonic stem cells & induced pluripotent stem cells were observed in March 2020.
Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the local presence of a substantial number of key players such as Thermo Fisher Scientific, Merck KGaA, and Cell Signaling Technology Inc., among others, coupled with an upsurge in research and development spending by key players to develop innovative and advanced products, are attributed for the regional cell signaling industry growth.
For instance, in September 2023, Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.
Market Segmentation
By Product Type
• Consumables
• Instruments
• Reagent and Kits
By Signaling Type
• Endocrine Signaling
• Paracrine Signaling
• Autocrine Signaling
• Synaptic Signaling
• Others
By Pathway
• AKT Signaling Pathway
• AMPK Signaling Pathway
• ErbB/HER Signaling Pathway
• Others
By Technology
• Flow Cytometry
• Mass Spectrometry
• Western Blotting
• ELISA
• Others
By End User
• Hospitals
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fischer Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Merck KGaA, PerkinElmer Inc., Promega Corporation, Qiagen NV, Beijing Boshumei Biotechnology Co., Ltd among others.
Key Developments
 In February 2023, Bio-Techne Corporation and Cell Signaling Technology (CST) announced the addition of Simple Western validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on a trusted and validated platform.
 In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced a partnership to help increase local availability of next-generation sequencing (NGS)-based screening for patients with lung & breast cancer in more than 30 countries across Latin America, the Middle East, Africa, and Asia where advanced genomic testing was previously limited or unavailable.

Why Purchase the Report?
• To visualize the global cell signaling market segmentation based on product type, signaling type, pathway, technology, end user and region as well as understand key commercial assets and players.
• identify commercial opportunities by analyzing trends and co-development.
• excel data sheet with numerous data points of the cell signaling market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global cell signaling market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Signaling Type
3.3. Snippet by Pathway
3.4. Snippet by Technology
3.5. Snippet by End User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of chronic diseases
4.1.1.2. Rise of technological advancement in cell-based signaling research
4.1.2. Restraints
4.1.2.1. Ethical issues related to embryonic stem cell signaling research
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Reagent and Kits
8. By Signaling Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
8.1.2. Market Attractiveness Index, By Signaling Type
8.2. Endocrine Signaling*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Paracrine Signaling
8.4. Autocrine Signaling
8.5. Synaptic Signaling
8.6. Others
9. By Pathway
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
9.2. Market Attractiveness Index, By Pathway
9.3. AKT Signaling Pathway*
9.3.1. Introduction
9.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.4. AMPK Signaling Pathway
9.5. ErbB/HER Signaling Pathway
9.6. Others
10. By Technology
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.1.2. Market Attractiveness Index, By Technology
10.2. Flow Cytometry*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Mass Spectrometry
10.4. Western Blotting
10.5. ELISA
10.6. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Pharmaceutical and Biotechnology Companies
11.4. Academic and Research Institutions
11.5. Contract Research Organizations (CROs)
11.6. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), Technology
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), Technology
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), Technology
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), Technology
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. South Korea
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Signaling Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pathway
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), Technology
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Thermo Fisher Scientific, Inc*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Becton, Dickinson and Company
14.3. Bio-Rad Laboratories Inc
14.4. Bio-Techne Corporation
14.5. Cell Signaling Technology Inc
14.6. Merck KGaA
14.7. PerkinElmer Inc
14.8. Promega Corporation
14.9. Qiagen NV
14.10. Beijing Boshumei Biotechnology Co., Ltd
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific, Inc, 4.	Key Developments, Becton, Dickinson and Company, Bio-Rad Laboratories Inc, Bio-Techne Corporation, Cell Signaling Technology Inc, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV, Beijing Boshumei Biotechnology Co., Ltd

표 목록 (Tables)

List of Tables

Table 1 Global Cell Signaling Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Cell Signaling Market Value, By Signaling Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Cell Signaling Market Value, By Pathway, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Cell Signaling Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Cell Signaling Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Cell Signaling Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Cell Signaling Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 9 Global Cell Signaling Market Value, By Signaling Type, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 11 Global Cell Signaling Market Value, By Pathway, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 13 Global Cell Signaling Market Value, By Technology, 2023, 2027 & 2031 (US$ Million)

Table 14 Global Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 15 Global Cell Signaling Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 16 Global Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 17 Global Cell Signaling Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 18 Global Cell Signaling Market Value, By Region, 2022-2031 (US$ Million)

Table 19 North America Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 20 North America Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 21 North America Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 22 North America Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 23 North America Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 24 North America Cell Signaling Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 29 Asia-Pacific Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Asia-Pacific Cell Signaling Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Europe Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Europe Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 33 Europe Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 34 Europe Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 35 Europe Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 36 Europe Cell Signaling Market Value, By Country, 2022-2031 (US$ Million)

Table 37 South America Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 38 South America Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 39 South America Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 40 South America Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 41 South America Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 42 South America Cell Signaling Market Value, By Country, 2022-2031 (US$ Million)

Table 43 Middle East and Africa Cell Signaling Market Value, By Product Type, 2022-2031 (US$ Million)

Table 44 Middle East and Africa Cell Signaling Market Value, By Signaling Type, 2022-2031 (US$ Million)

Table 45 Middle East and Africa Cell Signaling Market Value, By Pathway, 2022-2031 (US$ Million)

Table 46 Middle East and Africa Cell Signaling Market Value, By Technology, 2022-2031 (US$ Million)

Table 47 Middle East and Africa Cell Signaling Market Value, By End User, 2022-2031 (US$ Million)

Table 48 Middle East and Africa Cell Signaling Market Value, By Country, 2022-2031 (US$ Million)

Table 49 Thermo Fischer Scientific Inc: Overview

Table 50 Thermo Fischer Scientific Inc: Product Portfolio

Table 51 Thermo Fischer Scientific Inc: Key Developments

Table 52 Becton, Dickinson and Company: Overview

Table 53 Becton, Dickinson and Company: Product Portfolio

Table 54 Becton, Dickinson and Company: Key Developments

Table 55 Bio-Rad Laboratories Inc: Overview

Table 56 Bio-Rad Laboratories Inc: Product Portfolio

Table 57 Bio-Rad Laboratories Inc: Key Developments

Table 58 Bio-Techne Corporation: Overview

Table 59 Bio-Techne Corporation: Product Portfolio

Table 60 Bio-Techne Corporation: Key Developments

Table 61 Cell Signaling Technology Inc: Overview

Table 62 Cell Signaling Technology Inc: Product Portfolio

Table 63 Cell Signaling Technology Inc: Key Developments

Table 64 Merck KGaA: Overview

Table 65 Merck KGaA: Product Portfolio

Table 66 Merck KGaA: Key Developments

Table 67 PerkinElmer Inc: Overview

Table 68 PerkinElmer Inc: Product Portfolio

Table 69 PerkinElmer Inc: Key Developments

Table 70 Promega Corporation: Overview

Table 71 Promega Corporation: Product Portfolio

Table 72 Promega Corporation: Key Developments

Table 73 Qiagen NV: Overview

Table 74 Qiagen NV: Product Portfolio

Table 75 Qiagen NV: Key Developments

Table 76 Beijing Boshumei Biotechnology Co., Ltd: Overview

Table 77 Beijing Boshumei Biotechnology Co., Ltd: Product Portfolio

Table 78 Beijing Boshumei Biotechnology Co., Ltd: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 3 Global Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 4 Global Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 5 Global Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 6 Global Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 7 Global Cell Signaling Market Share, By Region, 2023 & 2031 (%)

Figure 8 Global Cell Signaling Market Y-o-Y Growth, By Product Type, 2023-2031 (%)

Figure 9 Consumables Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 10 Instruments Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 11 Reagent and Kits Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 12 Global Cell Signaling Market Y-o-Y Growth, By Signaling Type, 2023-2031 (%)

Figure 13 Endocrine Signaling Signaling Type in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 14 Paracrine Signaling Signaling Type in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 15 Autocrine Signaling Signaling Type in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 16 Synaptic Signaling Signaling Type in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 17 Others Signaling Type in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 18 Global Cell Signaling Market Y-o-Y Growth, By Pathway, 2023-2031 (%)

Figure 19 AKT Signaling Pathway Pathway in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 20 AMPK Signaling Pathway Pathway in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 21 ErbB/HER Signaling Pathway Pathway in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 22 Others Pathway in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 23 Global Cell Signaling Market Y-o-Y Growth, By Technology, 2023-2031 (%)

Figure 24 Flow Cytometry Technology in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 25 Mass Spectrometry Technology in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 26 Western Blotting Technology in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 27 ELISA Technology in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 28 Others Technology in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 29 Global Cell Signaling Market Y-o-Y Growth, By End User, 2023-2031 (%)

Figure 30 Hospitals End User in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 31 Pharmaceutical and Biotechnology Companies End User in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 32 Academic and Research Institutions End User in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 33 Contract Research Organizations (CROs) End User in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 34 Others End User in Global Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 35 Global Cell Signaling Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 36 North America Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 37 North America Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 38 North America Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 39 North America Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 40 North America Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 41 North America Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 42 North America Cell Signaling Market Share, By Country, 2023 & 2031 (%)

Figure 43 Asia-Pacific Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 44 Asia-Pacific Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 45 Asia-Pacific Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 46 Asia-Pacific Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 47 Asia-Pacific Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 48 Asia-Pacific Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 49 Asia-Pacific Cell Signaling Market Share, By Country, 2023 & 2031 (%)

Figure 50 Europe Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 51 Europe Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 52 Europe Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 53 Europe Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 54 Europe Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 55 Europe Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 56 Europe Cell Signaling Market Share, By Country, 2023 & 2031 (%)

Figure 57 South America Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 58 South America Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 59 South America Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 60 South America Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 61 South America Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 62 South America Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 63 South America Cell Signaling Market Share, By Country, 2023 & 2031 (%)

Figure 64 Middle East and Africa Cell Signaling Market Value, 2022-2031 (US$ Million)

Figure 65 Middle East and Africa Cell Signaling Market Share, By Product Type, 2023 & 2031 (%)

Figure 66 Middle East and Africa Cell Signaling Market Share, By Signaling Type, 2023 & 2031 (%)

Figure 67 Middle East and Africa Cell Signaling Market Share, By Pathway, 2023 & 2031 (%)

Figure 68 Middle East and Africa Cell Signaling Market Share, By Technology, 2023 & 2031 (%)

Figure 69 Middle East and Africa Cell Signaling Market Share, By End User, 2023 & 2031 (%)

Figure 70 Thermo Fischer Scientific Inc: Financials

Figure 71 Becton, Dickinson and Company: Financials

Figure 72 Bio-Rad Laboratories Inc: Financials

Figure 73 Bio-Techne Corporation: Financials

Figure 74 Cell Signaling Technology Inc: Financials

Figure 75 Merck KGaA: Financials

Figure 76 PerkinElmer Inc: Financials

Figure 77 Promega Corporation: Financials

Figure 78 Qiagen NV: Financials

Figure 79 Beijing Boshumei Biotechnology Co., Ltd: Financials

글로벌 세포 신호 전달 시장 – 2024-2031년

Global Cell Signaling Market - 2024-2031